Pfizer, Bristol-Myers Can't Revive Eliquis Patent At EPO
Pfizer and a Bristol-Myers Squibb unit have failed to rescue their jointly owned patent over the blockbuster blood thinner Eliquis in Europe after eight rivals convinced an appeals panel that the...To view the full article, register now.
Already a subscriber? Click here to view full article